U.K. regulator reportedly expected to greenlight Oxford-AstraZeneca vaccine this week


The United Kingdom's Medicines and Healthcare Products Regulatory Agency is preparing to approve the COVID-19 vaccine developed by the University of Oxford and AstraZeneca at some point next week, The Telegraph and The Times report.
British ministers are reportedly drawing up plans to roll out the vaccine by Jan. 4. The U.K. has already approved and administered the Pfizer-BioNTech vaccine, and the government reportedly wants 2 million people to receive either shot within two weeks in the hopes of easing intense lockdowns across the country prompted by a new coronavirus variant that may be more transmissible.
There have been discrepancies in the Oxford-AstraZeneca trials when it comes to the vaccine's efficacy, though it's considered safe. New data reportedly suggests the candidate ultimately proved to be as effective as the Moderna and Pfizer-BioNTech vaccines, which registered above 90 percent, but some experts remain skeptical. Tim O'Donnell
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
One great cookbook: ‘The Woks of Life’
The Week Recommends A family’s opinionated, reliable take on all kinds of Chinese cooking
-
Digital addiction: the compulsion to stay online
In depth What it is and how to stop it
-
Can Trump bully Netanyahu into Gaza peace?
Today's Big Question The Israeli leader was ‘strong-armed’ into new peace deal
-
FDA OKs generic abortion pill, riling the right
Speed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
RFK Jr. vaccine panel advises restricting MMRV shot
Speed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials